A. van der Does (Leiden, Netherlands), C. Beisswenger (Homburg (Saar), Germany), M. Hylkema (NH Haren, Netherlands), S. Di Vincenzo (Palermo (PA), Italy)
LSC - 2018 - Characterization of decellularized COPD lung matrices using mass spectrometry proteomics
F. Uhl, B. Zvarova (Barbora.Zvarova@uvm.edu / University of Vermont, C. of Medicine,Burlington, V. , B. Ahlers (Bethany.Ahlers@uvm.edu / University of Vermont, V. Genetics Network,Burlington, V. , C. Hood (Catrina.Hood@uvm.edu / University of Vermont, V. Genetics Network,Burlington, V. , B. Deng (Bin.Deng@uvm.edu / University of Vermont, D. of Biology,Burlington, V. , Y. Lam (Ying-Wai.Lam@uvm.edu / University of Vermont, D. of Biology,Burlington, V. , E. Beatman (BeatmanE@NJHealth.org / National Jewish Health,Denver, C. , K. Schweitzer (SchweitzerK@NJHealth.org / National Jewish Health, D. of Pulmonary, C. Care and Sleep Medicine,Denver, C. , I. Petrache (PetracheI@NJHealth.org / National Jewish Health, D. of Pulmonary, C. Care and Sleep Medicine,Denver, C. , D. Weiss (daniel.weiss@uvm.edu / University of Vermont, C. of Medicine,Burlington, V. , D. Wagner (darcy.wagner@med.lu.se / Lund University,Lund)
|  |
Protease anti-protease imbalance and small airways disease in COPD
N. Tanabe (Kyoto, Japan), A. Sato (Kyoto, Japan), T. Mizutani (Kyoto, Japan), Y. Hamakawa (Kyoto, Japan), K. Uemasu (Kyoto, Japan), S. Sato (Kyoto, Japan), S. Muro (Kyoto, Japan), T. Hirai (Kyoto, Japan)
| |
MMP-12 activates protease activated receptor (PAR)-1, upregulates placenta growth factor and leads to pulmonary emphysema
H. Hou (Taipei, Taiwan), H. Wang (Taipei, Taiwan), C. Yu (Taipei, Taiwan)
| |
Supervising differentiation for tailoring the airway epithelial cell phenotype
C. Vernisse (Montpellier, France), N. Drappier (Montpellier, France), A. Fort (Montpellier, France), L. Knabe (Montpellier, France), I. Vachier (Montpellier, France), D. Gras (Marseille, France), P. Chanez (Marseille, France), E. Ahmed (Montpellier, France), A. Bourdin (Montpellier, France)
| |
Change of secretory activity of goblet cells of bronchial epithelium in asthma patients in response to cold airway challenge
J. Perelman (Blagoveshchensk, Russian Federation), A. Pirogov (Blagoveshchensk, Russian Federation), A. Prikhodko (Blagoveshchensk, Russian Federation), S. Zinoviev (Blagoveshchensk, Russian Federation), A. Kolosov (Blagoveshchensk, Russian Federation), X. Zhou (Haikou, China), Q. Li (Haikou, China), E. Ushakova (Blagoveshchensk, Russian Federation)
|  |
Investigating epithelial plasticity following cigarette smoke exposure in primary human bronchial epithelium
K. Nishida (Baltimore, United States of America), S. Chen (Baltimore, United States of America), J. Nguyen (Baltimore, United States of America), A. Keller (Baltimore, United States of America), V. Agarwal (Baltimore, United States of America), V. Sidhaye (Baltimore, United States of America)
| |
The effect of anticancer drugs on mucociliary clearance of bronchial ciliary cells in mice
N. Tamiya (Kyoto, Japan), S. Hosogi (Kyoto, Japan), T. Nakahari (Kyoto, Japan), Y. Marunaka (Kyoto, Japan), K. Takayama (Kyoto, Japan)
| |
Cigarette smoke induces mitochondrial dysfunction via PKCd-p66Shc signaling pathway in human bronchial epithelial cells
M. Zhang (Xi'an, China), Y. Li (Xi'an, China), J. Tang (Xi'an, China), J. Zhang (Xi'an, China), X. Yang (Xi'an, China), H. Shan (Xi'an, China), Q. Zhang (Xi'an, China)
| |
Iron Oxide and Titanium Dioxide Nanoparticles Reduce Alveolar Epithelial Cell Stiffening and Contraction Forces
I. Almendros (Barcelona, Spain), V. Oliveira (Barcelona, Spain), J. Uriarte (Barcelona, Spain), W. Zin (Rio de Janeiro, Brazil), D. Navajas (Barcelona, Spain), R. Farré (Barcelona, Spain)
| |
Junctional modulation by lipopolysaccharide on epithelial damage caused by diesel exhaust particles
N. Kim (Seoul, Republic of Korea), M. Park (Seoul, Republic of Korea)
| |
Therapeutic effect of small molecule C in experimental COPD model
J. Lee (chuncheon, Republic of Korea), H. Lee (chuncheon, Republic of Korea), S. Yang (chuncheon, Republic of Korea)
| |
Creatine Supplementation Augments Chronic Allergic Airway Inflammation and Remodelling: from Mice to Human Evidence
M. Garcia (São José dos Campos, Brazil), A. Santos-Dias (São José dos Campos, Brazil), A. Santos Andrade-Souza (São José dos Campos, Brazil), M. Carneiro Oliveira-Junior (São José dos Campos, Brazil), S. César-Ferreira (São José dos Campos, Brazil), F. Maria Almeida (São José dos Campos, Brazil), N. Cristine Rigonato-Oliveira (São Paulo, Brazil), A. Ligeiro Oliveira (São Paulo, Brazil), T. Siepmann (Dresden, Germany), M. Idzko (Vienna, Brazil), T. Müller (Aachen, Germany), R. Paula Vieira (São Paulo, Brazil)
| |
ADAM17 protects mice against elastase-induced emphysema via inactivation of CD62L
S. Suzuki (Tokyo, Japan), M. Ishii (Tokyo, Japan), T. Asakura (Tokyo, Japan), H. Namkoong (Tokyo, Japan), S. Okamori (Tokyo, Japan), K. Yagi (Tokyo, Japan), H. Kamata (Tokyo, Japan), T. Kusumoto (Tokyo, Japan), S. Kagawa (Tokyo, Japan), A. Hegab (Tokyo, Japan), K. Horiuchi (Tokyo, Japan), N. Hasegawa (Tokyo, Japan), T. Betsuyaku (Tokyo, Japan)
| |
Cigarette smoking induced elevated CXCL5 levels in BALF and plasma of patients with COPD
J. Chen (Chengdu, China), T. Wang (Chengdu, China), L. Dai (Chengdu, China), F. Wen (Chengdu, China)
| |
Anti-inflammatory effect of hypoxic signaling suppression in the severe COPD model.
O. Titova (St-Petersburg, Russian Federation), N. Kuzubova (St-Petersburg, Russian Federation), E. Lebedeva (St-Petersburg, Russian Federation)
| |
Altered protein turnover signaling and myogenesis during impaired recovery of inflammation-induced muscle atrophy in emphysematous mice
R. Langen (Maastricht, Netherlands), J. Ceelen (Maastricht, Netherlands), A. Kneppers (Maastricht, Netherlands), C. De Theije (Maastricht, Netherlands), S. Van Hoof (Maastricht, Netherlands), F. Verhaegen (Maastricht, Netherlands), A. Schols (Maastricht, Netherlands)
| |
Extracellular matrix glycosaminoglycans can predict severity and outcome in COPD
E. Papakonstantinou (Basel, Switzerland), I. Bonovolias (Thessaloniki, Greece), G. Karakiulakis (Thessaloniki, Greece), M. Tamm (Basel, Switzerland), R. Louis (Liege, Belgium), B. Milenkovic (Belgrade, Republic of Serbia), W. Boersma (Alkmaar, Netherlands), K. Kostikas (Larissa, Greece), F. Blassi (Milan, Italy), J. Aerts (Breda, Netherlands), G. Rohde (Maastrict, Netherlands), A. Lacoma (Badalona, Spain), A. Torres (Barcelona, Spain), T. Welte (Hannover, Germany), D. Stolz (Basel, Switzerland)
| |
Cigarette smoke induces overexpression of cathepsin S in active smokers with and without COPD
M. Wartenberg (Tours, France), P. Andrault (Tours, France), A. Schamberger (Munich, Germany), T. Chazeirat (Tours, France), D. Sizaret (Tours, France), J. Renault (Tours, France), A. Petit (Tours, France), A. Saidi (Tours, France), S. Guyetant (Tours, France), Y. Courty (Tours, France), O. Eickelberg (Tours, France), G. Lalmanach (Tours, France), F. Lecaille (Tours, France)
| |
AGER gene expression and alternative splicing in bronchial biopsies of smokers and non-smokers
S. Pouwels (Groningen, Netherlands), C. Vermeulen (Groningen, Netherlands), V. Guryev (Groningen, Netherlands), M. Van Den Berge (Groningen, Netherlands), N. Ten Hacken (Groningen, Netherlands), A. Faiz (Groningen, Netherlands)
| |
Impairment of lung organoid formation by cigarette smoke treatment of mesenchymal cells
P. Khedoe (Leiden, Netherlands), J. Ng-Blichfeldt (Groningen, Netherlands), A. Van Schadewijk (Leiden, Netherlands), S. Marciniak (Cambridge, United Kingdom), M. Koenigshoff (Denver, United States of America), R. Gosens (Groningen, Netherlands), J. Stolk (Leiden, Netherlands), P. Hiemstra (Leiden, Netherlands)
| |